Page last updated: 2024-08-17

trypan blue and Cystadenocarcinoma, Serous

trypan blue has been researched along with Cystadenocarcinoma, Serous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Auersperg, N; Cheng, JC; Leung, PC	1

Other Studies

1 other study(ies) available for trypan blue and Cystadenocarcinoma, Serous

Article	Year
TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells. PloS one, 2012, Volume: 7, Issue:8 Topics: Apoptosis; Benzamides; Caspase 3; Cystadenocarcinoma, Serous; Dioxoles; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Ovarian Neoplasms; Phosphorylation; Prognosis; RNA, Small Interfering; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Trypan Blue; Tumor Suppressor Protein p53	2012

Article

Year

TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.

PloS one, 2012, Volume: 7, Issue:8

Topics: Apoptosis; Benzamides; Caspase 3; Cystadenocarcinoma, Serous; Dioxoles; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Ovarian Neoplasms; Phosphorylation; Prognosis; RNA, Small Interfering; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Trypan Blue; Tumor Suppressor Protein p53

2012